Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – What’s Next?

Hypermarcas (OTCMKTS:HYPMY)’s share price gapped down before the market opened on Monday . The stock had previously closed at $4.17, but opened at $3.97. Hypermarcas shares last traded at $3.97, with a volume of 155 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Hypermarcas Stock Down 2.8%

The company has a 50 day moving average of $4.33 and a 200 day moving average of $4.40. The stock has a market capitalization of $2.85 billion, a price-to-earnings ratio of 8.45 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. On average, research analysts forecast that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.